Literature DB >> 18326740

Nrl-knockout mice deficient in Rpe65 fail to synthesize 11-cis retinal and cone outer segments.

Kecia L Feathers1, Arkady L Lyubarsky, Naheed W Khan, Karen Teofilo, Anand Swaroop, David S Williams, Edward N Pugh, Debra A Thompson.   

Abstract

PURPOSE: To define rod and cone function further in terms of visual cycle mechanism, the retinal phenotype resulting from Rpe65 (retinoid isomerase I) deficiency in Nrl(-)(/)(-) mice having a single class of photoreceptors resembling wild-type cones was characterized and outcomes of retinoid supplementation evaluated.
METHODS: Rpe65(-)(/)(-)/Nrl(-)(/)(-) mice were generated by breeding Rpe65(-)(/)(-) and Nrl(-)(/)(-) strains. Retinal histology, protein expression, retinoid content, and electroretinographic (ERG) responses were evaluated before and after treatment with 11-cis retinal by intraperitoneal injection. Results Retinas of young Rpe65(-)(/-)/Nrl(-)(/-) mice exhibited normal lamination, but lacked intact photoreceptor outer segments at all ages examined. Rpe65, Nrl, and rhodopsin were not detected, and S-opsin and M/L-opsin levels were reduced. Retinyl esters were the only retinoids present. In contrast, Nrl(-)(/)(-) mice exhibited decreased levels of retinaldehydes and retinyl esters, and elevated levels of retinols. ERG responses were elicited from Rpe65(-)(/-)/Nrl(-)(/-) mice only at the two highest intensities over a 4-log-unit range. Significant retinal thinning and outer nuclear layer loss occurred in Rpe65(-)(/-)/Nrl(-)(/-) mice with aging. Administration of exogenous 11-cis retinal did not rescue retinal morphology or markedly improve ERG responses.
CONCLUSIONS: The findings provide clarification of reported cone loss of function in Rpe65(-)(/-)/Nrl(-)(/-) mice, now showing that chromophore absence results in destabilized cone outer segments and rapid retinal degeneration. The data support the view that rod-dominant retinas do not have a cone-specific mechanism for 11-cis retinal synthesis and have potential significance for therapeutic strategies for rescue of cone-rich retinal regions affected by disease in the aging human population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326740      PMCID: PMC4505835          DOI: 10.1167/iovs.07-1234

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  44 in total

1.  Identification of the RPE65 protein in mammalian cone photoreceptors.

Authors:  Sergey L Znoiko; Rosalie K Crouch; Gennadiy Moiseyev; Jian-Xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

2.  Isomerization and oxidation of vitamin a in cone-dominant retinas: a novel pathway for visual-pigment regeneration in daylight.

Authors:  Nathan L Mata; Roxana A Radu; Richard C Clemmons; Gabriel H Travis
Journal:  Neuron       Date:  2002-09-26       Impact factor: 17.173

3.  RPE65 is the isomerohydrolase in the retinoid visual cycle.

Authors:  Gennadiy Moiseyev; Ying Chen; Yusuke Takahashi; Bill X Wu; Jian-Xing Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

4.  RPE65 is essential for the function of cone photoreceptors in NRL-deficient mice.

Authors:  Andreas Wenzel; Johannes von Lintig; Vitus Oberhauser; Naoyuki Tanimoto; Christian Grimm; Mathias W Seeliger
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

5.  The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration.

Authors:  A Wenzel; C E Reme; T P Williams; F Hafezi; C Grimm
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

6.  Rhodopsin C terminus, the site of mutations causing retinal disease, regulates trafficking by binding to ADP-ribosylation factor 4 (ARF4).

Authors:  Dusanka Deretic; Andrew H Williams; Nancy Ransom; Valerie Morel; Paul A Hargrave; Anatol Arendt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

7.  Retinoid requirements for recovery of sensitivity after visual-pigment bleaching in isolated photoreceptors.

Authors:  G J Jones; R K Crouch; B Wiggert; M C Cornwall; G J Chader
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Identification and characterization of rod-derived cone viability factor.

Authors:  Thierry Léveillard; Saddek Mohand-Saïd; Olivier Lorentz; David Hicks; Anne-Claire Fintz; Emmanuelle Clérin; Manuel Simonutti; Valérie Forster; Nükhet Cavusoglu; Frédéric Chalmel; Pascal Dollé; Olivier Poch; George Lambrou; José-Alain Sahel
Journal:  Nat Genet       Date:  2004-06-27       Impact factor: 38.330

9.  Human cone photoreceptor dependence on RPE65 isomerase.

Authors:  Samuel G Jacobson; Tomas S Aleman; Artur V Cideciyan; Elise Heon; Marcin Golczak; William A Beltran; Alexander Sumaroka; Sharon B Schwartz; Alejandro J Roman; Elizabeth A M Windsor; James M Wilson; Gustavo D Aguirre; Edwin M Stone; Krzysztof Palczewski
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

Review 10.  Cone rod dystrophies.

Authors:  Christian P Hamel
Journal:  Orphanet J Rare Dis       Date:  2007-02-01       Impact factor: 4.123

View more
  28 in total

1.  Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.

Authors:  J Pang; S E Boye; B Lei; S L Boye; D Everhart; R Ryals; Y Umino; B Rohrer; J Alexander; J Li; X Dai; Q Li; B Chang; R Barlow; W W Hauswirth
Journal:  Gene Ther       Date:  2010-03-18       Impact factor: 5.250

Review 2.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

Review 3.  RPE65: role in the visual cycle, human retinal disease, and gene therapy.

Authors:  Xue Cai; Shannon M Conley; Muna I Naash
Journal:  Ophthalmic Genet       Date:  2009-06       Impact factor: 1.803

4.  Formation of all-trans retinol after visual pigment bleaching in mouse photoreceptors.

Authors:  Chunhe Chen; Lorie R Blakeley; Yiannis Koutalos
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

5.  Loss of human disease protein retinitis pigmentosa GTPase regulator (RPGR) differentially affects rod or cone-enriched retina.

Authors:  Kollu N Rao; Linjing Li; Wei Zhang; Richard S Brush; Raju V S Rajala; Hemant Khanna
Journal:  Hum Mol Genet       Date:  2016-01-24       Impact factor: 6.150

6.  Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.

Authors:  Artur V Cideciyan; Tomas S Aleman; Sanford L Boye; Sharon B Schwartz; Shalesh Kaushal; Alejandro J Roman; Ji-Jing Pang; Alexander Sumaroka; Elizabeth A M Windsor; James M Wilson; Terence R Flotte; Gerald A Fishman; Elise Heon; Edwin M Stone; Barry J Byrne; Samuel G Jacobson; William W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

7.  Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration.

Authors:  Fan Yang; Hongwei Ma; Joshua Belcher; Michael R Butler; T Michael Redmond; Sanford L Boye; William W Hauswirth; Xi-Qin Ding
Journal:  FASEB J       Date:  2016-09-13       Impact factor: 5.191

8.  An alternative pathway mediates the mouse and human cone visual cycle.

Authors:  Jin-Shan Wang; Vladimir J Kefalov
Journal:  Curr Biol       Date:  2009-09-24       Impact factor: 10.834

9.  Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography.

Authors:  M Dominik Fischer; Gesine Huber; Susanne C Beck; Naoyuki Tanimoto; Regine Muehlfriedel; Edda Fahl; Christian Grimm; Andreas Wenzel; Charlotte E Remé; Serge A van de Pavert; Jan Wijnholds; Marek Pacal; Rod Bremner; Mathias W Seeliger
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

10.  Intra-retinal visual cycle required for rapid and complete cone dark adaptation.

Authors:  Jin-Shan Wang; Maureen E Estevez; M Carter Cornwall; Vladimir J Kefalov
Journal:  Nat Neurosci       Date:  2009-02-01       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.